5889.T
JAPAN EYEWEAR HOLDINGS CO LTD

Healthcare · Medical Instruments & Supplies · valued as of 2026-11-03 · statements 2026-01-31

Average Intrinsic Value

389.04M USD

Market Cap

337.22M USD

Margin of Safety

13.3%

Intrinsic / Market Ratio

1.15×

Projections, not exact values. Intrinsic Values are projected from each company's past reports. They show which stocks look cheap compared with the others, not exactly what a stock is worth.

How Each Value Is Built

The screener's three formulas on the reported figures. Each card reads the same way: the value as a sum of numbered terms, each term's calculation opened under it, from the reported figures to the value. The list ranks companies by their plain average over the market cap.

EPV + Growth

386.13M USD

what the normal year's earnings are worth for ever, plus growth that pays

Profit

509.76M USD

15 years of cash the shareholders can take out, and the equity left at year 15

FCFF

271.22M USD

15 years of cash for shareholders and lenders, less what is owed

Intrinsic Value

389.04M USD

the plain average of the three, uncapped, as the screener averages them

Intrinsic Value

389.04M USD

from the sum above

Market Cap

337.22M USD

the price on the date above times the shares

Intrinsic Value ÷ Market Cap

1.15×

the ratio the screener ranks by; Margin of Safety +13.3% (1 − Market Cap ÷ Intrinsic Value)

Each card below builds one of the three values from the reported years.

Earnings power value plus growth: 386.13M USD
What the normal year's operating profit after tax is worth if it lasts for ever, plus what the new investment adds beyond its cost, less the net debt that comes before the shareholders (or plus the net cash).
①EPV (earnings power value)414.63M USD
−②Net Debt Today76.35M USD
+③Growth Value47.84M USD
=Value386.13M USD

EPV of the Operations (NOPAT over WACC)

414.63M USD

Net debt today

-76.35M USD

Growth Value

+47.84M USD

Value

386.13M USD

①EPV (earnings power value)

414.63M USD

②Net Debt Today

76.35M USD

③Growth Value

47.84M USD

Market value

Market Cap337.22M USD

The price on the date above times the shares.

Value vs market

Margin of Safety+12.7%

1 minus the market cap as a share of the value.

Profit value: today's value of the shareholders' equity, from the cash it can pay them (FCFE): 509.76M USD
Fifteen years of free cash flow to equity (FCFE), each brought to today at the cost of equity, plus the equity at year 15 brought to today.
①Present Value of the 15 Years of FCFE297.45M USD
+②Equity at Year 15, Today212.32M USD
=Value509.76M USD
FCFE: the net income left for the shareholders once the business keeps what next year's growth needsEquity reinvestment: the part of the year's net income kept in the business to grow the next year; below zero, capital the business releases to the shareholdersPresent value of the FCFEColoured bars show the FCFE, grey bars the equity reinvestment. With a positive equity reinvestment the two stacked are the year's normalized income; with a negative one the grey is below zero, capital the business releases, and the normalized income is the FCFE plus that negative amount. Shaded, years 6 to 10: the growth falling to its long-run rate and the ROE on new investment falling to the cost of equity. Axes linear.

①Present Value of the 15 Years of FCFE

297.45M USD

②Equity at Year 15, Today

212.32M USD

Market value

Market Cap337.22M USD

The price on the date above times the shares.

Value vs market

Margin of Safety+33.8%

1 minus the market cap as a share of the value.

FCFF value: today's value of the shareholders' equity, from the cash the firm can pay its shareholders and lenders (FCFF): 271.22M USD
Fifteen years of free cash flow to the firm (FCFF), each brought to today at the WACC, plus the invested capital at year 15 brought to today, less the net debt today (or plus the net cash).
①Present Value of the 15 Years of FCFF225.88M USD
+②Invested Capital at Year 15, Today121.68M USD
−③Net Debt Today76.35M USD
=Value271.22M USD
FCFF: the NOPAT left for the shareholders and the lenders once the business reinvests what next year's growth needsReinvestment: the part of the year's NOPAT put back into the business to grow the next year; below zero, capital the business releasesPresent value of the FCFFColoured bars show the FCFF, grey bars the reinvestment. With a positive reinvestment the two stacked are the year's NOPAT; with a negative one the grey is below zero, capital the business releases, and the NOPAT is the FCFF plus that negative amount. Shaded, years 6 to 10: the growth rising to its long-run rate and the ROIC on new investment falling to the WACC. Axes linear.

①Present Value of the 15 Years of FCFF

225.88M USD

②Invested Capital at Year 15, Today

121.68M USD

③Net Debt Today

76.35M USD

Market value

Market Cap337.22M USD

The price on the date above times the shares.

Value vs market

Margin of Safety-24.3%

1 minus the market cap as a share of the value.

The Rates and the Capital the Values Read

The WACC and the cost of equity each value is discounted at, the book value and the net debt each starts from, and the seven quality metrics, from the same run.

WACC: 5.47%
Cost of Equity =Risk-Free Rate 4.50%+Beta 0.35×Market Risk Premium 6.00%= 6.63%

The yearly return the shareholders require for the risk they carry; it is the rate that brings their future cash to today.

Tax Rate for WACC =Tax Provision 12.03M USDPretax Income 36.75M USD= 32.72%

The tax the interest saves.

Interest Expense =EBIT 38.96M USD−Pretax Income 36.75M USD= 2.21M USD

The interest the company paid: EBIT is the profit before tax plus the interest.

Cost of Debt =Interest Expense 2.21M USDTotal Debt 98.95M USD×(1 − Tax Rate for WACC 32.72%)= 1.50%

What the lenders are paid a year after the tax the interest saves.

Debt Weight =Total Debt 98.95M USDMarket Cap + Total Debt 337.22M USD + 98.95M USD= 22.69%

The part of the capital the lenders put in, at market value.

WACC =Equity Weight 77.31%×Cost of Equity 6.63%+Debt Weight 22.69%×Cost of Debt 1.50%= 5.47%

Weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.

Book value and net debt today
Both from the balance sheet of the newest quarter, 2026-07-31.

Total Assets 257.32M USD − Total Liabilities 135.42M USD = Book Value Today 121.89M USD

Total Debt 98.95M USD − Cash and Short-Term Investments 22.60M USD = Net Debt Today 76.35M USD

The book value is what Profit starts from and what stands when a projection is not made; the book value plus the net debt is what FCFF starts from; the net debt comes off Greenwald's and FCFF's values before the shareholders.

Quality metrics
Read beside the value, never a condition for it: every company is valued, and a filter in the list is the reader's choice.
MetricFrom
Share dilutionShares Today ÷ Shares Two Years Back − 11.3%at most 5%passes24,244,380 / 23,944,260
Accrual quality(Operating Cash Flow − Net Income) ÷ Total Assets4.0%at least -10.0%passes(35.05M USD − 24.72M USD) ÷ 257.32M USD
Price to bookMarket Cap ÷ Book Value Today2.77×at most 3×passes337.22M USD ÷ 121.89M USD
Operating marginOperating Income ÷ Revenue32.0%above 10.0%passes38.93M USD ÷ 121.82M USD
Revenue growthRevenue ÷ Revenue a Year Before − 112.5%above 10.0%passes121.82M USD / 108.26M USD
Net cash(Cash − Total Debt) ÷ Market Cap-22.6%above -30%passes(22.60M USD − 98.95M USD) ÷ 337.22M USD
Operating efficiencyOperating Income ÷ Gross Profit40.6%above 25.0%passes38.93M USD ÷ 95.89M USD

Market Data

The provider's ratios and the analysts' consensus beside the argument; none of them enters a value.

Share price

2181.18 JPY

Enterprise value

65.11B JPY

the provider's own figure

EV / EBITDA

7.58×

Price / book

2.71×

the provider's book

Price / earnings

12.47×

Return on equity

23.4%

the provider's figure, not this page's

Profit margin

21.4%

Revenue growth

13.9%

Analyst target, mean

—

Analysts

—

opinions in the consensus

Financial Statements

The annual lines the screener holds, year by year, in USD at each period's rate; the figures this valuation read are in its calculation above.

USD2023202420252026
Income statement

Revenue

82.26M91.89M108.26M121.82M

Gross profit

63.01M71.22M85.39M95.89M

Operating income

17.08M25.13M34.61M38.93M

EBITDA

operating income before depreciation and amortisation

27.82M35.22M45.52M51.45M

Pretax income

10.01M22.38M31.91M36.75M

Net income

2.24M15.06M25.94M24.72M

Normalized income

net income without one-off items, as the data provider prints it; Profit's line when printed

2.24M15.06M25.94M24.72M

R&D

————
Balance sheet, year end

Total assets

239.13M236.15M252.26M260.84M

Total liabilities

169.47M146.01M145.59M141.98M

Shareholders' equity

the equity the parent's shareholders own, as printed, without minority interest; the book value the values read is total assets less total liabilities, in Book Value and Net Debt above

35.87M90.14M106.67M118.86M

Total debt

131.25M111.79M108.15M101.98M

Cash and equivalents

16.95M30.06M25.54M19.96M

Net PP&E

fixed assets after depreciation

34.75M36.29M55.41M60.07M

Working capital

current assets less current liabilities

3.38M20.02M14.39M-60.32M
Cash flow

Operating cash flow

22.52M23.41M34.16M35.05M

Capital expenditure

paid out, so below zero

-2.45M-5.25M-14.15M-4.71M

Depreciation and amortisation

10.74M10.06M10.88M12.49M

Free cash flow

operating cash flow plus capital expenditure

20.07M18.16M20.00M30.34M